Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2014 1
2017 1
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract.
Lastraioli E, Iorio J, Petrelli F, Tomezzoli A, Battista S, Ambrosio MR, Chiudinelli M, De Salvatore F, Messerini L, Villanacci V, Saragoni L, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG). Lastraioli E, et al. Curr Issues Mol Biol. 2022 Mar 17;44(3):1326-1331. doi: 10.3390/cimb44030089. Curr Issues Mol Biol. 2022. PMID: 35723312 Free PMC article.
Preneoplastic lesions represent a useful target for early diagnosis and follow-up of gastrointestinal malignancies. hERG1 channel expression was tested by immunohistochemistry (IHC) in a cohort of colorectal adenoma samples belonging to Italian subjects. ...The highest exp …
Preneoplastic lesions represent a useful target for early diagnosis and follow-up of gastrointestinal malignancies. hERG1 channel exp …
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples.
Lastraioli E, Romoli MR, Iorio J, Lottini T, Chiudinelli M, Bencivenga M, Vindigni C, Tomezzoli A, De Manzoni G, Compagnoni B, Manzi I, Messerini L, Saragoni L, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG). Lastraioli E, et al. Onco Targets Ther. 2019 Nov 7;12:9377-9384. doi: 10.2147/OTT.S226257. eCollection 2019. Onco Targets Ther. 2019. PMID: 31807018 Free PMC article.
PURPOSE: Gastric cancer (GC) is still a relevant health issue worldwide. The identification of prognostic factors for progression of gastric dysplasia (GD), the main pre-cancerous lesion of the intestinal-type GC, is hence mandatory. ...No association emerged betwee …
PURPOSE: Gastric cancer (GC) is still a relevant health issue worldwide. The identification of prognostic factors for progression of …
The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to gastric cancer surgery with curative intent.
Farsi M, Bernini M, Bencini L, Miranda E, Manetti R, de Manzoni G, Verlato G, Marrelli D, Pedrazzani C, Roviello F, Marchet A, Cristadoro L, Gerard L, Moretti R; GIRCG (Gruppo Italiano di Ricerca sul Cancro Gastrico). Farsi M, et al. Trials. 2009 May 15;10:32. doi: 10.1186/1745-6215-10-32. Trials. 2009. PMID: 19445661 Free PMC article. Clinical Trial.
Therefore, some surgeons perform routine concomitant cholecystectomy during standard surgery for gastric malignancies. However, not all the patients who are diagnosed to have cholelithiasis after gastric cancer surgery will develop symptoms or require additional sur …
Therefore, some surgeons perform routine concomitant cholecystectomy during standard surgery for gastric malignancies. However, not a …
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort.
Lastraioli E, Boni L, Romoli MR, Crescioli S, Taddei A, Beghelli S, Tomezzoli A, Vindigni C, Saragoni L, Messerini L, Bernini M, Bencini L, Giommoni E, Freschi G, Di Costanzo F, Scarpa A, Morgagni P, Farsi M, Roviello F, De Manzoni G, Bechi P, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG). Lastraioli E, et al. Eur J Surg Oncol. 2014 Oct;40(10):1291-8. doi: 10.1016/j.ejso.2014.03.028. Epub 2014 Apr 12. Eur J Surg Oncol. 2014. PMID: 24784776
PURPOSE: The clinical significance of VEGF-A expression in gastric cancer (GC) has been reported with contradicting results. ...
PURPOSE: The clinical significance of VEGF-A expression in gastric cancer (GC) has been reported with contradicting results. ...
Effect of neoadjuvant chemotherapy on HER-2 expression in surgically treated gastric and oesophagogastric junction carcinoma: a multicentre Italian study.
Chiari D, Orsenigo E, Guarneri G, Baiocchi GL, Mazza E, Albarello L, Bissolati M, Molfino S, Staudacher C; Gruppo Italiano Ricerca Cancro Gastrico (GIRCG). Chiari D, et al. Updates Surg. 2017 Mar;69(1):35-43. doi: 10.1007/s13304-017-0423-2. Epub 2017 Mar 8. Updates Surg. 2017. PMID: 28276033
Predictors of response to neoadjuvant chemotherapy are not available for gastric and oesophago-gastric junction carcinoma. HER-2 over-expression in breast cancer correlates with poor prognosis and high incidence of recurrence. ...HER-2 negativity may represent a pre …
Predictors of response to neoadjuvant chemotherapy are not available for gastric and oesophago-gastric junction carcinoma. HER …